Leap and Siro Unite to Unlock Total Sales Transparency With New Integration in SalesPro

PR NewswireOct 28 08:00 ET

Leap Therapeutics Completes Enrollment in Part B of DeFianCe Study

TipRanksSep 30 07:11 ET

Express News | Leap Therapeutics Announces Completion of Enrollment in Part B of the Defiance Study of Dkn-01 for the Treatment of Colorectal Cancer Patients

ReutersSep 30 07:00 ET

Leap LLC Secures Spot on the Inc. 5000 Fastest-Growing Companies List for the Fourth Consecutive Year

PR NewswireAug 14 08:03 ET

Baird Maintains Leap Therapeutics(LPTX.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsAug 13 10:31 ET · Ratings

Optimistic Buy Rating on Leap Therapeutics Amid Promising Phase 2 Cancer Trial Outcomes

TipRanksAug 13 09:52 ET · Ratings